Hrithik Roshan To Promote Cure.fit, Signs Deal Worth Rs 100 Crore
Bengaluru: Health and wellness start-up Cure.fit announced on Tuesday Rs. 100-crore partnership with Bollywood star Hrithik Roshan, who will promote Cure.fit through his lifestyle and fitness brand HRX.
This strategic association is expected to accelerate Bengaluru-headquartered Cure.fit's pan-India expansion plans.
The company said its growth plan over the next five years includes adding 500 new Cult outlets -- Cure.fit's chain of fitness centres -- across India.
"Cure.fit's growing popularity amongst consumers validates the need for holistic, preventive healthcare solutions in the country. Our partnership with HRX will enable us to expand our market presence and consumer base," Cure.fit co-founder Mukesh Bansal said in a statement.
"Hrithik is admired for the incredible passion and discipline he devotes to his fitness regime, his association with us will chart new growth opportunities for Cure.fit," Bansal added.
Founded in 2016 by former Flipkart executives Ankit Nagori and Bansal, Cure.fit aims to address preventive healthcare through a combination of engagement, coaching and delivery using a mix of online and offline channels.
As part of the collaboration, Hrithik Roshan's signature workout, "HRX Workout", designed by him along with his personal trainer under his brand HRX, is available exclusively at all CULT centres and eventually will be made available on the Cure.fit mobile app, the company said in a statement.
HRX was founded in 2013 by Hrithik Roshan and Exceed Exnterntainment.
"I strongly believe in the philosophy of healthy living which is integral to brand HRX -- it is not just about being fit, but truly undergoing a transformation in your lifestyle and understanding the connection between mind and body," the Bollywood star said.
"What is most remarkable about Cure.fit is that it creates bespoke solutions for its customers. I look forward to furthering the HRX vision through this partnership," he added.
Â
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.